Top Markets
Coin of the day
Quantum Genomics S.A. Quantum Genomics S.A.

Quantum Genomics S.A.

ALQGC
Rank in Stocks #37063
Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France,... Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France, in 2005, focuses on creating treatments for cardiovascular ailments. Its therapeutic approach utilizes the brain aminopeptidase A inhibition (BAPAI) platform, primarily addressing high blood pressure (hypertension) and heart failure. The company's key asset, firibastat, is currently undergoing a crucial Phase III study as a standalone therapy for hypertension and is also in clinical trials for heart failure. Additionally, Quantum Genomics is progressing QGC011 for hypertension in combination therapy, and further developing QGC006 and QGC606 to target both hypertension and heart failure.
Share Price
$0.07600875
Last synced: 2024-11-20
Market Cap
$2.06M
Change (1 day)
-0.51%
Change (1 year)
0.00%
Country
FR
Trade Quantum Genomics S.A. (ALQGC)

Category

Stock price history for Quantum Genomics S.A. (ALQGC)
Highest end of day price: $0.08 on 2024-11-01

Lowest end of day price: $37.53 on 2010-05-01
Stock price history of Quantum Genomics S.A. from 2010 to 2026
Annual Stock Price Performance
Year Performance
2024 -31.57%
2023 -20.96%
2022 -97.03%
2021 -17.53%
2020 70.38%
2019 -45.87%
2018 78.19%
2017 -51.24%
2016 -20.35%
2015 46.29%
2014 -23.21%
2013 -37.92%
2012 -61.96%
2011 -5.11%
2010 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE